Back
BioLine Rx Stock Price Chart
Sponsored
BLRX
Sponsored
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
28
BLRX
BioLine Rx
Last Price:
$0.23
Seasonality Move:
-8.21%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BioLine Rx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.21 | Buy |
20-day SMA: | 0.24 | Sell |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 0.62 | Sell |
8-day EMA: | 0.22 | Buy |
20-day EMA: | 0.26 | Sell |
50-day EMA: | 0.35 | Sell |
200-day EMA: | 0.64 | Sell |
BioLine Rx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 37.16 | Sell |
Chaikin Money Flow: | 730302 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.18 - 0.36) | Sell |
Bollinger Bands (100): | (0.33 - 0.67) | Sell |
BioLine Rx Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BioLine Rx Stock
Is BioLine Rx Stock a Buy?
-
BioLine Rx share price is 0.23 while BLRX 8-day simple moving average is 0.21, which is a Buy signal.
-
The stock price of BLRX is 0.23 while BioLine Rx 20-day SMA is 0.24, which makes it a Sell.
-
BioLine Rx 50-day simple moving average is 0.36 while BLRX share price is 0.23, making it a Sell technically.
-
BLRX stock price is 0.23 and BioLine Rx 200-day simple moving average is 0.62, creating a Sell signal.
BLRX Technical Analysis vs Fundamental Analysis
Sell
28
BioLine Rx (BLRX)
is a Sell
Is BioLine Rx a Buy or a Sell?
-
BioLine Rx stock is rated a SellThe current BioLine Rx [BLRX] share price is $0.23. The Score for BLRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
BioLine Rx Stock Info
Market Cap:
19.6M
Price in USD:
0.23
Share Volume:
840.5K
BioLine Rx 52-Week Range
52-Week High:
1.64
52-Week Low:
0.19
Sell
28
BioLine Rx (BLRX)
is a Sell
BioLine Rx Share Price Forecast
-
What is the BioLine Rx stock price today?The BioLine Rx stock price is 0.23 USD today.
-
Will BLRX stock go up or go down?BioLine Rx> share price is forecast to RISE/FALL based on technical indicators
-
Is BioLine Rx overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioLine Rx is overvalued.
Is BioLine Rx Stock a Buy?
-
BioLine Rx share price is 0.23 while BLRX 8-day exponential moving average is 0.22, which is a Buy signal.
-
The stock price of BLRX is 0.23 while BioLine Rx 20-day EMA is 0.26, which makes it a Sell.
-
BioLine Rx 50-day exponential moving average is 0.35 while BLRX share price is 0.23, making it a Sell technically.
-
BLRX stock price is 0.23 and BioLine Rx 200-day simple moving average is 0.64, creating a Sell signal.
Fundamental Analysis of BioLine Rx
Is BioLine Rx a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.90 per share, and a decrease next year of $0.03 per share.
Technical Analysis of BioLine Rx
Should I short BioLine Rx stock?
-
BLRX Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting BioLine Rx is a Sell
-
BioLine Rx Relative Strength Index (RSI) is 37.16, which suggest BioLine Rx is oversold
-
The Bollinger Bands (25) for BioLine Rx is (0.18 - 0.36), which suggest BioLine Rx is a Sell
-
The Bollinger Bands (100) for BioLine Rx is (0.33 - 0.67), which suggest BioLine Rx is a Sell
* BioLine Rx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.